The 2-Minute Rule for api in pharmaceutical manufacturing
“The present situation has uncovered some structural weaknesses while in the EU’s medicines source chain in addition to a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She advisable that supply chain problems be dealt with in an EU pharmaceutical method envisioned for being released by the